Haisen Pharm
00136717.472.67% ( -0.48 )
Haisen Pharm (001367)
Zhejiang Haisen Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermedi...
- Open
- 17.87
- High
- 18.10
- Low
- 17.40
- Prev. Close
- 17.95
- Volume
- 11.83K
- Turnover
- 20.95M
- Avg Price
- 17.72
- Bid/Ask Ratio
- 69.41%
- Amplitude
- 3.90%
- 52wk High
- 27.88
- Volume Ratio
- 0.44
- Turnover Ratio
- 0.79%
News
- London Stock Exchange · 2 days ago, 05:06 AM
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
- benzinga_article · Jul 24 at 05:25 AM
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
- Zhitong · Oct 21, 2025 at 03:58 AM
Haisen Pharm released its performance for the first three quarters, with a net profit attributable to the parent company of 88.2096 million yuan, an increase of 1.45%
- Zhitong · Aug 14, 2025 at 05:42 AM
Haisen Pharm: Net profit of 60.7942 million yuan in the first half of 2025, a year-on-year increase of 4.74%
- Zhitong · Aug 5, 2025 at 08:52 PM
The generic drug consistency evaluation sector has declined in the short term, with Guilin Sanjin falling over 6%
- Zhitong · May 29, 2025 at 06:35 AM
Haisen Pharm General Manager Ai Lin plans to reduce holdings of no more than 0.97% of shares
